BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7120069)

  • 1. Disposition of quinidine in the rabbit.
    Guentert TW; Huang JD; Oie S
    J Pharm Sci; 1982 Jul; 71(7):812-5. PubMed ID: 7120069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    Yu VC; de Lamirande E; Horning MG; Pang KS
    Drug Metab Dispos; 1982; 10(6):568-72. PubMed ID: 6130901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of serum protein binding on the pharmacokinetics of quinidine in normal and anuric rats.
    Fremstad D; Jacobsen S; Lunde KM
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):161-76. PubMed ID: 579055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of quinidine metabolism and plasma protein binding by phenobarbital in dogs.
    Rakhit A; Holford NH; Effeney DJ; Riegelman S
    J Pharmacokinet Biopharm; 1984 Oct; 12(5):495-515. PubMed ID: 6520745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal quinidine binding in survivors of prehospital cardiac arrest.
    Kessler KM; Lisker B; Conde C; Silver J; Ho-Tung P; Hamburg C; Myerburg RJ
    Am Heart J; 1984 Apr; 107(4):665-9. PubMed ID: 6702560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition kinetics of quinidine.
    Ueda CT; Hirschfeld DS; Scheinman MM; Rowland M; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Jan; 19(1):30-6. PubMed ID: 1245091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of disposition parameters of quinidine and quinine in the rat.
    Watari N; Wakamatsu A; Kaneniwa N
    J Pharmacobiodyn; 1989 Oct; 12(10):608-15. PubMed ID: 2630631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Mar; 66(3):395-407. PubMed ID: 845807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of quinidine in rats with carbon tetrachloride-intoxicated hepatic disease.
    Sugihara N; Furuno K; Kita N; Murakami T; Yata N
    J Pharmacobiodyn; 1992 Apr; 15(4):167-74. PubMed ID: 1494979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.
    Drayer DE; Hughes M; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1980 Jan; 27(1):72-5. PubMed ID: 7351119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine.
    Hardy BG; Zador IT; Golden L; Lalka D; Schentag JJ
    Am J Cardiol; 1983 Jul; 52(1):172-5. PubMed ID: 6858908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic studies on drug disposition in rabbits. II. Dose dependent pharmacokinetics of sulfamethizole.
    Katayama K; Ohtani H; Murai A; Kakemi M; Koizumi T
    J Pharmacobiodyn; 1990 Feb; 13(2):108-19. PubMed ID: 2384847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function.
    Drayer DE; Lowenthal DT; Restivo KM; Schwartz A; Cook CE; Reidenberg MM
    Clin Pharmacol Ther; 1978 Jul; 24(1):31-9. PubMed ID: 657716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.
    Ueda CT; Ballard B; Rowland M
    J Pharmacol Exp Ther; 1977 Mar; 200(3):459-68. PubMed ID: 403278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinidine and dihydroquinidine interactions in human plasma.
    Ueda CT; Makoid MC
    J Pharm Sci; 1979 Apr; 68(4):448-50. PubMed ID: 438966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced quinidine clearance in elderly persons.
    Ochs HR; Greenblatt DJ; Woo E; Smith TW
    Am J Cardiol; 1978 Sep; 42(3):481-5. PubMed ID: 356577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.